Cato Research Boston Company Profile

07:15 EDT 23rd September 2017 | BioPortfolio

Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.


Westpark Corporate Centre, 4364 South Alston Avenue
United States of America


Phone: 919 361 2286
Fax: 919 361 2290

News Articles [1073 Associated News Articles listed on BioPortfolio]

Boston Scientific pledges $19M to Irish endoscopy research, design facility

Boston Scientific has committed to invest approximately $19 million by 2020 in endoscopy research and in its new RoadRunner e -More- 

Iranian scientist traveling to Boston for cancer research is detained

Boston Children’s Hospital says it is “doing its utmost” to support the researcher, Mohsen Dehnavi, and hopes he is released soon.

Mayo Clinic and Boston Software Maker Add Qrativ to Busy A.I. Sector

Artificial intelligence systems have become a trendy, but useful means of extracting meaning out of the troves of scientific research and clinical data that institutions produce every year. Startups f...

NHL players slow to donate brains for concussion research

Body:  According to Ann McKee, MD, chief of neuropathology at VA Boston and director of Boston University’s CTE Center, hockey is falling behind football in posthumous brain donation."We're not...

BU rheumatologist receives international award

(Boston University Medical Center) This year's Carol Nachman Prize for Rheumatology was awarded to David T. Felson, MD, PhD, professor of medicine and epidemiology at Boston University's Schools of Me...

Rapid hepatitis C testing may help better screen young adults

(Boston Medical Center) Routine and rapid hepatitis C virus testing among young adults who use injection drugs improves life expectancy and may provide a good use of limited resources, according to ne...

NIH awards BU more than $5 million to continue Alzheimer's research

(Boston University School of Medicine) The National Institutes of Health/National Institute on Aging has awarded the Boston University Alzheimer's Disease Center (BU ADC) a three-year, $5.4 million gr...

#jobs #lifescience DeltaV Automation Engineer – BOSTON/CAMBRIDGE

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: DeltaV Automation Engineer – BOSTON/CAMBRIDGE .MA-Cambridge, We are a B...

PubMed Articles [1849 Associated PubMed Articles listed on BioPortfolio]

Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients.

Screening out patients who do not require immediate surgery is a growing trend in the field of thyroid research. In this study, we retrospectively compared the application of two surveillance selectio...

Age and composite end-point events in medium follow-up of patients with carotid artery total occlusion using drug therapy.

The outcome of carotid artery total occlusion (CATO) is unclear. The aim of this study is to report the medium incidence of composite end-point events and risk factors (especially age), in patients wi...

The Boston Marathon versus the World Marathon Majors.

To compare finish times across WMM races for Boston, London, Berlin, Chicago and New York Marathons.

Catalyzing Interdisciplinary Research and Training: Initial Outcomes and Evolution of the Affinity Research Collaboratives Model.

Team science has been recognized as critical to solving increasingly complex biomedical problems and advancing discoveries in the prevention, diagnosis, and treatment of human disease. In 2009, the Ev...

Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.

The loss of vision following Boston Keratoprosthesis (BKPro) surgery due to glaucoma occurs at a high frequency as diagnosis and management of glaucoma after this procedure pose challenges.

Clinical Trials [1063 Associated Clinical Trials listed on BioPortfolio]

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

The Boston Scientific ACCESS Trial

The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialys...

EXCEL: Change in Cardiometabolic Disease Risk Factors During an Interactive Fitness Program

Childhood obesity has increased in prevalence over the past several decades and is predictive of adult type 2 diabetes and cardiovascular disease (CVD). Recent studies of children and yout...

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project

To determine whether the Boston Scientific nitinol drug-eluting stent shows acceptable performance at 9 months when treating Superficial Femoral (SFA) and/or Proximal Popliteal Artery (PPA...

Companies [1395 Associated Companies listed on BioPortfolio]

Cato Research Boston

Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiousl...

Cato Research Ltd.

Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiousl...

Advanced Pain Remedies

Headquartered near Research Triangle Park, NC, APR is majority owned and virtually run by Cato BioVentures. APR will work with Advanced Targeting Systems, Cato Research and Cato BioVentures to develop...

Hemodynamic Therapeutics, Inc.

HTI was formed in 2004 as a majority-owned portfolio company of Cato BioVentures. Through its strategic development relationship with Cato BioVentures and its contract research and development affilia...

Boston Strategics

Boston Strategics is an integrated biotechnology research and development company with experience in developing, managing and optimizing global drug development programs from late...

More Information about "Cato Research Boston" on BioPortfolio

We have published hundreds of Cato Research Boston news stories on BioPortfolio along with dozens of Cato Research Boston Clinical Trials and PubMed Articles about Cato Research Boston for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cato Research Boston Companies in our database. You can also find out about relevant Cato Research Boston Drugs and Medications on this site too.

Quick Search

Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record